REVIEW
Accepted on 21 Oct 2025
Durvalumab Consolidation Therapy in Patients with Stage III Small Cell Lung Cancer after Concurrent Chemoradiation: A China-based Cost-effectiveness Analysis
- 372 views
5,361
Total downloads
23k
Total views and downloads
REVIEW
Accepted on 21 Oct 2025
ORIGINAL RESEARCH
Accepted on 20 Oct 2025
ORIGINAL RESEARCH
Accepted on 20 Oct 2025
ORIGINAL RESEARCH
Published on 19 Sep 2025
ORIGINAL RESEARCH
Published on 15 Sep 2025
ORIGINAL RESEARCH
Published on 08 Sep 2025
ORIGINAL RESEARCH
Published on 05 Sep 2025
ORIGINAL RESEARCH
Published on 29 Aug 2025
ORIGINAL RESEARCH
Published on 12 Jun 2025
ORIGINAL RESEARCH
Published on 11 Jun 2025
ORIGINAL RESEARCH
Published on 09 Jun 2025
ORIGINAL RESEARCH
Published on 30 May 2025
